Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01030692 · ClinicalTrials.gov registry record · Phase 1
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
A Phase 1 study of Substance Abuse and Cocaine Dependence, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT01030692 is a Phase 1 study of Substance Abuse and Cocaine Dependence that has completed, run by Baylor College of Medicine. The registered enrollment target is 72 participants, below the 5,259-participant average among 58 other Substance Abuse trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01030692, a Phase 1 study of Substance Abuse and Cocaine Dependence, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the safety and effects of rivastigmine and huperzine A (HupA), potential treatments for cocaine abuse, when used before experimental administration of cocaine, on a number of physical and psychological measures.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Rivastigmine 3 mg
- DRUG Huperzine A 0.4 mg
- DRUG Rivastigmine 6 mg
- DRUG Huperzine A 0.8 mg
Study Locations (1)
Texas
- Michael E. DeBakey Veterans Affairs Medical Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2009-01 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01030692
The ClinicalTrials.gov registry entry for NCT01030692 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,259-participant average among 58 other Substance Abuse trials with a reported enrollment target (99% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Substance Abuse appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT01030692 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01030692 about?
NCT01030692 is a clinical study titled "Rivastigmine and Huperzine A as Treatments for Cocaine Dependence". The purpose of this study is to determine the safety and effects of rivastigmine and huperzine A (HupA), potential treatments for cocaine abuse, when used before experimental administration of cocaine, on a number of physical and psychological measures.
What is the current status of trial NCT01030692?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2009-01. Estimated completion is 2014-06.
What conditions does trial NCT01030692 study?
This clinical trial studies the following conditions: Substance Abuse, Cocaine Dependence, Cocaine Abuse, Cocaine Addiction.
What interventions are being tested in trial NCT01030692?
The interventions under investigation include: Placebo (DRUG), Rivastigmine 3 mg (DRUG), Huperzine A 0.4 mg (DRUG), Rivastigmine 6 mg (DRUG), Huperzine A 0.8 mg (DRUG).
Who is sponsoring clinical trial NCT01030692?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01030692 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use
COMPLETED · Phase 1
-
Computer Based Training in Cognitive Behavioral Therapy Web-based
COMPLETED · Phase 1
-
Safety Interaction Trial Ibudilast and Methamphetamine
COMPLETED · Phase 1
-
Adolescent Involvement in Parental Substance Abuse Treatment
COMPLETED · Phase 1
-
Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education
COMPLETED · Phase 1
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.